Tenderwize
Back to tender search

Purchase and successive delivery of palivizumab

Uniwersyteckie Centrum Zdrowia Kobiety i Noworodka Warszawskiego Uniwersytetu Medycznego Sp. z o.o.·Warszawa, Poland·Deadline Dec 14, 2026 · 24 days left·Open·Supplies
Original notice title

Poland – Infusion solutions – Zakup i sukcesywne dostawy leku palivizumab. UCZKIN.ZP.15.2026.EU

0/100

Opportunity Score

High riskLow complexity
SuppliesOpen
Why this score?

Opportunity

0 / 100

Complexity

0 / 100

Deep Portfolio Analysis

Deep Company Fit Analysis

Uses:

  • Description
  • Industries & Services
  • Capabilities
  • Market & Experience
  • Certifications

Tender facts

Contracting authority
Uniwersyteckie Centrum Zdrowia Kobiety i Noworodka Warszawskiego Uniwersytetu Medycznego Sp. z o.o.
Country
Poland
CPV
33692100 - Infusion solutions
Deadline
Dec 14, 2026

AI tender analysis

Tenderwize prepares an AI analysis of this tender based on the TED notice and procurement documents: scope of work, key requirements, eligibility criteria, risks and questions for the buyer. The analysis is generated when the tender is opened.

Award Criteria

Lot 1

Cena= (cena najtańszej oferty/ cena oferty badanej) x 100

Buyer

Lots (1)

LOT-0001

Zakup i sukcesywne dostawy leku palivizumab UCZKIN.ZP.15.2026.EU

Dostawa produktu leczniczego stosowanego w profilaktyce zakażeń wirusem RS dla Uniwersyteckiego Centrum Zdrowia Kobiety i Noworodka Warszawskiego Uniwersytetu Medycznego Sp. z o.o. w Warszawie.

SuppliesEU fundedElectronic submission

Location

Warszawa, Poland

Duration

Jan 2027 - Apr 2027

Category

Infusion solutions

Award Criteria

Cena= (cena najtańszej oferty/ cena oferty badanej) x 100

Procurement Details

Publication date
11 Nov 2026
Languages
Polish

Reference metadata

Legal basis
32014L0024

Reference IDs

Tender ID
787584-2026

Documents (1)

Similar tenders

Cookies & Privacy

With your consent, we use Google Analytics, Microsoft Clarity (session recordings) and Google Ads cookies to understand how Tenderwize is used and to measure our advertising. You can change your choice at any time via “Cookie Settings” in the footer. Cookie Policy · Privacy Policy